- Mayo Clinic, Hitachi to build new oncology facility
- Japan grants ODD to Merck's investigational therapy Tepotinib
- Toray signs pact with JICA to support infection control capacity
- CStone announces first patient dosed in the Phase I study of ivosidenib
- Duke-NUS introduces Clinical Sciences PhD programme in translational research
- BookDoc Made it to the CNBC Top 100 World's Most Promising Start-ups
- Excelra Collaborates with Maruho for Drug Repurposing
- ABL Bio inks strategic partnership with GenScript
- ITM, CIRC promote medical radioisotopes in China
- India seeks to build 21st Century Health System
- Novo Nordisk explores liver cell targets with Dicerna
- NTU makes novel discovery in diabetes research
- WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody
- Baring Private Equity Asia to acquire Lumenis
-
Singapore | 04 July 2019 | News
Latest technologies to transform healthcare
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on th...Read more
Europe | 05 November 2019 | Influencers
TPP Commits To Transform The Delivery of Health and Care Globally
Nov Special Interview - Malaysia. TPP is a healthcare technology company, dedicated to delivering world...Read more
-
India | 20 November 2019 | News
Excelra Collaborates with Maruho for Drug Repurposing
Excelra, a leading global Data and Analytics Company on 20 Nov 2019 announced a Drug Repurposing collaboration...Read more
-
North America | 20 November 2019 | News
Mayo Clinic, Hitachi to build new oncology facility
Mayo Clinic and Hitachi, Ltd. have reached an agreement in principle to build a carbon ion treatment fac...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Needs much more for world without diabetes
Diabetes is on the rise across the globe as reported in the most recent 8th edition of the International Diabetes Federation (IDF) Diabetes Atlas 2017. As Diabetes is a lifestyle disease, it can be prevented by adopting appropriate lifestyle. This is what the evidence from studies conducted in the USA, Finland, China, India and Japan have proved. However, the pharma industry has been investing on R&D and launching new products but needs much more. From January 2019 to October 31, 2019, the US FDA has approved three products for type 2 diabetes (two drugs Rybelsus and Victoza from Novo Nordisk and one drug – Farxiga from AstraZeneca).
